Tara Lachapelle, Columnist

Merger Meltdown

The Pfizer-Allergan merger is dead, and several other large deals have issues.

April 6, 2016 at 1:28 PM UTC

By Tara Lachapelle

Tara Lachapelle is a former Bloomberg Opinion columnist covering entertainment, telecommunications and deals.

Provide news feedback or report an error

Site feedback:

Take our Survey

This article is for subscribers only.

Last year was a big deal -- for deals. About $3.8 trillion of mergers and acquisitions were announced worldwide, setting a new record.1459887018299 For bankers, happy days were here again.

Well, sort of.